Advanced Cell Technology, Inc. will participate at the European Stem Cells & Regenerative Medicine Congress 2006, June 5-7, at Jumeirah Carlton Tower, London, United Kingdom. Michael D. West, Ph.D., Chairman, President and Chief Scientific Officer, is scheduled to take part in a panel discussion titled Realizing Therapeutic Potential, on Wednesday, June 7th. Dr. West will discuss strategies for the accelerated development of therapeutics from human embryonic stem cells, introduce the Company's ACTCellerate technology platform, and show data on the first new differentiated cells derived using the technology, designated ACTC60.
Genetic Engineering News
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Paige Earns CE Mark for Prostate Cancer Detection Solution
“Pathology practices around the world have begun to embrace digital pathology,” said Paige CEO Leo Grady.
Ranitidine Tests Find NDMA Levels Akin to Levels in Food, Woodcock Says
The agency asked manufacturers to voluntarily recall another H2 blocker nizatidine, or Axid, if they find NDMA above the acceptable daily intake level.
FDAnews Device Daily Bulletin
ADVANCED CELL TECHNOLOGY UNVEILS ACTCELLERATE TECHNOLOGY PLATFORM
June 8, 2006
